Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger
article has not abstract
Vyšlo v časopise:
Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger. PLoS Med 6(9): e32767. doi:10.1371/journal.pmed.1000156
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000156
Souhrn
article has not abstract
Zdroje
1. http://www.plosmedicine.org/static/ghostwriting.action
2. LeaA
2003 Totelle manuscripts sign-off and review [E-mail]. Available: http://www.plos.org/ghostwriting/Exhibits2/CONSG204-014513.TIF. Accessed 19 August 2009
3. The PLoS Medicine Editors 2009 An unbiased scientific record should be everyone's agenda. PLoS Med 6(2) e1000038 doi:10.1371/journal.pmed.1000038
4. SismondoS
2007 Ghost Management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Med 4(9) e286 doi:10.1371/journal.pmed.0040286
5. GøtzschePC
KassirerJP
WoolleyKL
WagerE
JacobsA
2009 What should be done to tackle ghostwriting in the medical literature? PLoS Med 6(2) e1000023 doi:10.1371/journal.pmed.1000023
6. WagerE
2007 Authors, ghosts, damned lies, and statisticians. PLoS Med 4(1) e34 doi:10.1371/journal.pmed.0040034
7. RossJS
HillKP
EgilmanDS
KrumholzHM
2008 Guest authorship and ghostwriting in publications related to rofecoxib. A case study of industry documents from rofecoxib litigation. JAMA 299 1800 1812
8. GøtzschePC
HróbjartssonA
JohansenHK
HaahrMT
AltmanDG
2007 Ghost authorship in industry-initiated randomised trials. PLoS Med 4(1) e19 doi:10.1371/journal.pmed.0040019
9. DeAngelisCD
FontanarosaPB
2008 Impugning the integrity of medical science the adverse effects of industry influence. JAMA 299 1833 1835
10. WAME 2005 Ghost writing initiated by commercial companies. Available: http://www.wame.org/resources/policies#ghost. Accessed 19 August 2009
11. WagerE
FieldEA
GrossmanL
2003 Good publication practice for pharmaceutical companies. Curr Med Res Opin 19: 149–154. Available: http://basic1.easily.co.uk/03100E/00605D/GPP.pdf. Accessed 19 August 2009
12. ICMJE 2008 Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication: Byline authors. Available: http://www.icmje.org/#author. Accessed 19 August 2009
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 9
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Changing Patterns of Dengue Epidemiology and Implications for Clinical Management and Vaccines
- Grading Quality of Evidence and Strength of Recommendations: A Perspective
- Inflammatory Markers and Outcomes in Cardiovascular Disease
- The GRADE System for Rating Clinical Guidelines